Share Us:

Blog

The JPD blog includes news items and articles of interest to the PD research and PD patient communities. Jon Palfreman has been the primary contributor to this section since 2013 (his blog posts can be found here), joined in 2018 by Benjamin Stecher (his blog posts can be found here). In the specific sections, articles from these authors can be found and these blog posts and stories relating to PD are unique content created for the journal website. Jon Palfreman also authors two sections called Neuroscientist's Corner and The Patient Perspective. Benjamin Stecher additionally authors a section called Tomorrow Edition Extracts. Contributions from guest bloggers are also included.

Jon Palfreman’s Blog

Toward Personalized Medicine for Those with Parkinson’s

Posted by Jon Palfreman, PhD on 1 May 2017

Neurologists often remark that Parkinson’s is a highly variable disease. Persons with Parkinson’s not only acquire the disease at different ages, they also manifest different clinical profiles, displaying symptoms that can progress at strikingly different rates. Read more.

Last comment on by Patti Manners,

Comment

3 comments

Bookmark

Comment

| Bookmark | | Follow

Guest Blog

The International Linked Clinical Trials Initiative: A Program of Hope for Parkinson’s Disease

Posted by Pim van Holst, on 5 December 2023

Cure Parkinson's (CP) started the international Linked Clinical Trials (iLCT) initiative to repurpose drugs for the treatment of Parkinson's disease (PD). Combining priorities with the Van Andel Institute (VAI), they hold an annual two-day meeting to present, examine, discuss, and prioritize suitable compounds for streamlining into clinical trials specifically for slowing down/stopping/reversing the progression of PD. I was an invited Parkinson’s patient advocate to the iLCT meeting held at the Van Andel Institute (Grand Rapids, MI, USA) last September 26-27, 2022. Herein is a synopsis of the iLCT program and meeting.

Last comment on by Patti Manners,

Comment

2 comments

Bookmark

Comment

| Bookmark | | Follow

Neuroscientist's Corner

Interview: Caroline Tanner

Posted by Jon Palfreman, PhD on 7 September 2013

Caroline (Carlie) Tanner had always planned to specialize in family medicine. But while a medical student in Chicago, she fell under the spell of neurologist Harold Klawans. Klawans – one of the first neurologist to use levodopa therapy with PD patients – convinced the young doctor that Parkinson’s was an exciting area of research and practice. Says Tanner, “The idea of being able to intervene with a transformative therapy like levodopa was very attractive, so after some soul-searching, I switched my concentration from family medicine to neurology.”